WealthTrust Fairport’s Biogen BIIB Stock Holding History

WealthTrust Fairport’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.92M	Buy	8,138 +948	+13%	+$299K	0.18%	89
2018 Q4	$2.16M	Buy	7,190 +473	+7%	+$151K	0.23%	81
2018 Q3	$2.37M	Buy	6,717 +58	+0.9%	+$20K	0.22%	81
2018 Q2	$1.93M	Sell	6,659 -83	-1%	-$23.3K	0.19%	89
2018 Q1	$1.85M	Buy	6,742 +409	+6%	+$127K	0.19%	88
2017 Q4	$2.02M	Buy	+6,333	New	+$2.03M	0.2%	84
2015 Q1	–	Sell	-259	Closed	-$88K	–	167
2014 Q4	$88K	Sell	259 -35	-12%	-$11.3K	0.01%	151
2014 Q3	$97K	Hold	294	–	–	0.01%	131
2014 Q2	$93K	Buy	294 +100	+52%	+$30.1K	0.01%	137
2014 Q1	$59K	Hold	194	–	–	0.01%	145
2013 Q4	$54K	Hold	194	–	–	0.01%	137
2013 Q3	$47K	Hold	194	–	–	0.01%	164
2013 Q2	$42K	Buy	+194	New	+$41.5K	0.01%	168

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WealthTrust Fairport's BIIB Position: Q1 2019 in Review

WealthTrust Fairport increased its Biogen (BIIB) stake by 13% in Q1 2019, buying an estimated $299K and bringing the position to 8,138 shares worth $1.92M. The position accounts for 0.18% of the portfolio, ranked #89.

WealthTrust Fairport first reported a position in BIIB in Q2 2013 and has held it in 13 quarters since. The position peaked at $2.37M in Q3 2018. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

WealthTrust Fairport held 8,138 shares of Biogen worth $1.92M as of Q1 2019.
WealthTrust Fairport bought 948 Biogen shares in Q1 2019, an estimated $299K.
Biogen made up 0.18% of WealthTrust Fairport's portfolio in Q1 2019, its #89 holding.
WealthTrust Fairport first reported a position in Biogen in Q2 2013 and has held it in 13 quarters since.
WealthTrust Fairport's Biogen position peaked at $2.37M in Q3 2018.
1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.